Recombinant B7-H2 (Prezalumab Biosimilar) 抗体
适用: 人
FACS, SPR, Func, ELISA, BLI
宿主: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原 See all B7-H2 (Prezalumab Biosimilar) products
- B7-H2 (Prezalumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
-
Human
- Expression System
- CHO Cells
-
克隆类型
- 单克隆
-
标记
- This B7-H2 (Prezalumab Biosimilar) antibody is un-conjugated
- 应用范围
- Flow Cytometry (FACS), Surface Plasmon Resonance (SPR), Functional Studies (Func), ELISA, Bio-Layer Interferometry (BLI)
- 原理
- Anti-B7-H2 / ICOSL / CD275 Reference Antibody (prezalumab)
- 序列
- EVQLVESGGG LVQPGGSLRL SCAASGFTFS SYWMSWVRQA PGKGLEWVAY IKQDGNEKYY VDSVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCAREG ILWFGDLPTF WGQGTLVTVS SASTKGPSVF PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSNFGTQ TYTCNVDHKP SNTKVDKTVE RKCCVECPPC PAPPVAGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVQFNWYVD GVEVHNAKTK PREEQFNSTF RVVSVLTVVH QDWLNGKEYK CKVSNKGLPA PIEKTISKTK GQPREPQVYT LPPSREEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPMLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK,DIQMTQSPSS LSASVGDRVT ITCRASQGIS NWLAWYQQKP EKAPKSLIYA ASSLQSGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQQ YDSYPRTFGQ GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
- 产品特性
- Anti-B7-H2 / ICOSL / CD275 Reference Antibody (prezalumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
- 纯度
- >95 %
- 亚型
- IgG2SA
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 说明
-
Therapeutic Agents by Target and Mechanism: ICOS Ligand inhibitors
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 浓度
- 1 mg/mL
- 缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- 储存条件
- 4 °C,-80 °C
- 储存方法
- +4°C,-80°C
-
- 抗原
- B7-H2 (Prezalumab Biosimilar)
- Abstract
- B7-H2 (Prezalumab Biosimilar) 产品
- 物质类
- Biosimilar
- 分子量
- 145.5 kDa
- UniProt
- O75144
-
You are here:
